FDA Import Refusal 799-1550093-0/10002/1 — Lilly France S.A.S.
The FDA refused shipment 799-1550093-0/10002/1 from Lilly France S.A.S. (France) on September 5, 2025. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 5, 2025
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 118,3280